It has been postulated that active TB infection is immunosuppressive and that treatment of TB would lead to improved immune function and an increase in antigen-specific IFN-γ production by T cells.[17] Our data support an alternate hypothesis that treatment leads to decreased antigen burden and, in turn, diminished frequency of circulating antigen-specific T cells. The gene discussed is IFNG; the disease is tuberculosis.